Oppenheimer Assumes Aquestive Therapeutics (AQST) at Outperform (correction)
Tweet Send to a Friend
(Updated - June 2, 2025 8:50 AM EDT)
Oppenheimer analyst Matt Biegler assumes Aquestive Therapeutics (NASDAQ: AQST) at Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Matt Biegler assumes Aquestive Therapeutics (NASDAQ: AQST) at Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
